Literature DB >> 9721157

Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.

P Clavé1, A González, A Moreno, R López, A Farré, X Cussó, M D'Amato, F Azpiroz, F Lluís.   

Abstract

BACKGROUND & AIMS: Exogenous cholecystokinin (CCK) decreases lower esophageal sphincter (LES) pressure and increases transient LES relaxations (TLESRs) in humans. The aims of this study were to determine whether endogenous CCK increases gastroesophageal reflux in humans and whether this is a direct effect on the LES.
METHODS: Esophageal pH, LES pressure, and gallbladder volume were measured in 8 healthy volunteers after ingestion of a 181-kcal meal alone or adding 12 g cholestyramine to increase endogenous CCK release. In 7 additional volunteers, the effect of cholestyramine was studied during intravenous perfusion of saline or the CCK-A receptor antagonist loxiglumide. In circular LES strips from 9 transplant donors, we measured the effect of CCK-8 (10(-11) to 3 x 10(-8) mol/L) on basal tension and on electrical field-induced relaxation.
RESULTS: Cholestyramine increased gallbladder emptying, reflux episodes, TLESRs, and time of esophageal pH of <4. Loxiglumide inhibited postprandial gallbladder emptying, reflux episodes, TLESRs, and time of pH of <4 and prevented the decrease in LES pressure induced by cholestyramine. In vitro, CCK-8 contracted LES strips through a tetrodotoxin-insensitive pathway but did not modify electrical field-induced LES relaxations.
CONCLUSIONS: Endogenous CCK enhances postprandial gastroesophageal reflux in humans by increasing the rate of TLESRs and reduces postprandial LES pressure. These actions seem mediated by extrasphincteric CCK-A receptors that override a direct contractile effect of CCK on the LES muscle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721157     DOI: 10.1016/s0016-5085(98)70139-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Brain meets gut: gastroesophageal reflux.

Authors:  R F Pfeiffer
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

2.  A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms.

Authors:  Gregory L Austin; Michelle T Thiny; Eric C Westman; William S Yancy; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2006-07-27       Impact factor: 3.199

3.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

4.  Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan.

Authors:  Masatoshi Niigaki; Kyoichi Adachi; Kazuya Hirakawa; Kenji Furuta; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

5.  Motility Patterns Following Esophageal Pharmacologic Provocation With Amyl Nitrite or Cholecystokinin During High-Resolution Manometry Distinguish Idiopathic vs Opioid-Induced Type 3 Achalasia.

Authors:  Arash Babaei; Sadaf Shad; Benson T Massey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-13       Impact factor: 11.382

Review 6.  Bench-to-bedside review: the gut as an endocrine organ in the critically ill.

Authors:  Adam Deane; Marianne J Chapman; Robert J L Fraser; Michael Horowitz
Journal:  Crit Care       Date:  2010-09-24       Impact factor: 9.097

7.  Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.

Authors:  D P Hirsch; E M H Mathus-Vliegen; R H Holloway; N Fakhry; M D'Amato; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

8.  Cholecystokinin induces esophageal longitudinal muscle contraction and transient lower esophageal sphincter relaxation in healthy humans.

Authors:  Arash Babaei; Ravinder Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-14       Impact factor: 4.052

Review 9.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

Review 10.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.